Delivery Order SPE2DB22D2211-SPE2DB25FRPDK

Award Date 1/17/25
Potential Completion Date 2/10/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The $10,538.79 firm-fixed-price contract is for the delivery of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product, with a completion date of October 9, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This federal contract award is for the delivery of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $10,903.03 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 16, 2024, with a completion date of January 8, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $42,155.20, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on May 30, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 21, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the supply of the drug TAGRISSO 80 MG TABLET 30S. The contract has a ceiling value of $10,538.79 and is a firm fixed-price delivery order contract with a completion date of July 18, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product TAGRISSO 40 MG TABLET 30S. The contract has a completion date of March 1, 2024 and a potential value of $21,016.64. Amerisourcebergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to...
This federal contract award is for the delivery of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $10,093.47 and was awarded on September 24, 2022, with an ultimate completion date of October 17, 2022. It is a firm fixed-price delivery order contract, with no...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 30-count tablets of the drug TAGRISSO 80 MG. The contract has a completion date of March 12, 2024 and a potential value of $10,538.79. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a maximum contract ceiling of...
This federal contract award, valued at $10,247.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of TAGRISSO 80 MG TABLET 30S, with a completion date of May 19, 2023. The contract type is Firm Fixed Price, and it is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of the cancer medication TAGRISSO 80 MG TABLET 30S. The contract has a firm fixed price of $10,538.79 and a completion date of July 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,538.79, is for the delivery of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of November 25, 2024 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRPDK
    Delivery Order

The federal contract award is for the delivery of the pharmaceutical product TAGRISSO 80 MG TABLET 30S, with a ceiling value of $10,662.57. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order contract with a Firm Fixed Price pricing type, and the ultimate completion date is February 10, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/21/25, 3:44 AM